
Ms. Amanda
Address:
Building1-2, No. 20-2 Street, Economic&Technological Development Area, Hangzhou, Zhejiang, China
Telephone:
Zip Code:
Fax:
Please sign in to view contact details |
Account Registered in:
2020
Business Range:
Health & Medicine, Security & Protection
Management System Certification:
ISO 9001, BSCI, ISO 13485, FSC
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
As a national hi-tech enterprise, Zhejiang Barty Medical Technology Co., Ltd is committed to the R&D, production and sales of cardio vascular, peripheral vascular and medical equipment with high technology. The products mainly includes paclitaxel eluting PTCA balloon expansion catheter, paclitaxel eluting PTA balloon expansion catheter, paclitaxel-eluting peripheral stent system, PTA balloon ...
As a national hi-tech enterprise, Zhejiang Barty Medical Technology Co., Ltd is committed to the R&D, production and sales of cardio vascular, peripheral vascular and medical equipment with high technology. The products mainly includes paclitaxel eluting PTCA balloon expansion catheter, paclitaxel eluting PTA balloon expansion catheter, paclitaxel-eluting peripheral stent system, PTA balloon catheter, HP PTA balloon catheter, angiography catheter, guide catheter and catheter sheath sets.
With the building area of 5, 000 square meters, the company has established the Million level purification (local hundred level) clean workshop in line with the "GMP" requirements, equipped with professional, complete facilities and equipment.
The core management team consists of senior experts and therapists, who have ever worked at international famous foreign medical enterprise for more than 10 years.
Since its foundation, Barty has made many achievements, including about 20 core patents, CE certificate of 5 produces. Fore more, paclitaxel eluting PTCA balloon expansion catheter became the first to get "green channel" approved by SFDA in China. Paclitaxel-eluting peripheral stent system was selected as "2017 Zhejiang Key R&D project. " Barth Medical has already possessed the core competitive products and cutting-edge technologies.
With the building area of 5, 000 square meters, the company has established the Million level purification (local hundred level) clean workshop in line with the "GMP" requirements, equipped with professional, complete facilities and equipment.
The core management team consists of senior experts and therapists, who have ever worked at international famous foreign medical enterprise for more than 10 years.
Since its foundation, Barty has made many achievements, including about 20 core patents, CE certificate of 5 produces. Fore more, paclitaxel eluting PTCA balloon expansion catheter became the first to get "green channel" approved by SFDA in China. Paclitaxel-eluting peripheral stent system was selected as "2017 Zhejiang Key R&D project. " Barth Medical has already possessed the core competitive products and cutting-edge technologies.
International Commercial Terms(Incoterms):
FOB
Terms of Payment:
T/T, PayPal, Western Union
Average Lead Time:
Peak Season Lead Time: 1-3 months, Off Season Lead Time: one month
Number of Foreign Trading Staff:
>50 People
Export Year:
2015-08-01
Export Percentage:
31%~40%
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Nearest Port:
NNG BO
SHANGHAI
SHANGHAI
Import & Export Mode:
Have Own Export License
Export License Number: | 03389377 |
---|---|
Export Company Name: | Zhe Jiang Bark Medical Device Co., Ltd |
License Photo:
Factory Address:
Building1-2, No. 20-2 Street, Economic&Technological Development Area, Hangzhou, Zhejiang, China
R&D Capacity:
OEM, ODM, Own Brand(BARTY)
No. of R&D Staff:
11-20 People
No. of Production Lines:
8
Annual Output Value:
US$10 Million - US$50 Million
Ever Annual Output of Main Products:
Product Name | Units Produced (Previous Year) |
---|---|
PTA BALLOON CATHETER | 600000 Pieces |
INTRODUCER SHEATH CATHETER | 600000 Pieces |